posting velocity //
Loading…
Posting timing (day/hour) is available only when there are at least 5 jobs with a real publish stamp spread across 3 distinct days. This company's source doesn't expose post times, or there isn't enough data yet — showing what we know for sure: how many jobs are open, in which domains, and at which seniority levels.
Based on 2 events over 90 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
role mix //
—
The green layer is the current share of active openings by role. The grey dashed layer is the 90-day baseline — gaps between them show where the company is shifting its hiring mix.
seniority pyramid //
Seniority is not exposed by the source for this company.
Distribution of active openings by seniority. The 'unknown' row groups jobs from sources that don't expose seniority.
geography //
—
Active openings by region. Click a row to see jobs in that area.
time on market //
Median
28.2 days
25th pct
28.2 days
75th pct
28.2 days
Based on 2 closed jobs and 0 still open (right-censored). Curve is Kaplan-Meier; band is the 95% CI.Low event count — the median will stabilise after ~48 more closures. Until then treat the values as indicative.
Window: 180 days back. Don't read the mean — the long tail biases it. Median and percentiles are the honest summary.
Republish rate
—
Fewer than 10 closures in the window — not enough to compute.
The most prominent direct competitor is Boston Scientific, which markets the SpaceOAR hydrogel system. BioProtect's differentiation against the injectable hydrogel alternative lies in its pre-formed balloon structure, which is designed to provide a more symmetrical and predictable physical separation space.
The company's R&D, manufacturing, and executive headquarters are located in Tzur Yigal. In Israel, BioProtect employs primarily biomedical engineers, polymer chemists, clinical regulatory affairs professionals, and manufacturing personnel, backed by local venture capital firms such as Triventures and Almeda Ventures.
news feed
No recent news about this company.